SofWave
DeviceThe Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.
Other names: SUPERB
NCT Number: NCT06333067
Open-label, non-randomized single-arm prospective, multi-center, self-controlled clinical study with masked evaluation.
Interested in participating?
Request Info35 year–80 year
All sexes
Interventional
Not applicable
Costal Skin & Eye Institute, La Mesa, California, United States
Eligible patients will receive 1-2 face and/or neck and/or submental treatments (per PI discretion, 2-12 weeks apart) using the SofWave system with the Lift or/and Precise applicators.
Treatment may be administered after the enrollment and screening at the first visit, or it may occur at a later date following the enrollment and screening activities based on site scheduling availabilities.
All patients will return to the clinic for one follow-up visit at 3 months ± 2 weeks post last treatment (FU1).
Methodology described in the protocol to evaluate efficacy and safety of treatments will be carried out at each visit at the clinic.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.
Other names: SUPERB
Time frame: 3 months post treatment follow-up visit
Rate of improvement in the appearance of lax skin on the submental, neck zones and facial wrinkles following Sofwave treatments based on Global Aesthetic Improvement Scale, as evaluated by independent masked reviewers.
Contact information is provided by the study sponsor or research team.
Ruthie Amir, MD
CONTACT
Shlomit Mann, MSc
CONTACT
Sofwave Medical LTD
Industry
Safety and Efficacy of SofWave Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07685834
Body Weight, Body Weight Changes
Vancouver, Canada
View Trial DetailsNCT07187297
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
New York, United States
View Trial DetailsNCT07685821
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
San Diego, California, United States
View Trial DetailsNCT05358327
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
Sacramento, California, United States
View Trial Details